Fig. 1.
Comparative resistance of microbial strains
Fig. 2.
The percent of patients presenting comorbidities
Table 1.
Demographic and clinical characteristics of data collected from patients with screening samples by age and sex
| Screening samples | Comorbidities | Number of patients with susceptible results to different antibiotic classes, other than beta-lactamins | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Age | Sex | 0 | 1 | ≥2 | AG | FQ | SXT | Deceased | |
| <18 | Male | n= 2 6.25% | n=2 100% | - | - | - | - | - | - |
| Female | n= 1 3.12% | n=1 100% | - | - | - | - | - | - | |
| 19–60 | Male | n= 4 18.75% | - | n=1 16.66% | n=3 83.33% | n= 1 | n= 1 | - | n=4 100% |
| Female | n =2 6.25% | - | - | n=2 100% | n=1 | n=1 | - | n=0 | |
| >61 | Male | n= 20 62.5% | n=3 15% | n=5 25% | n=12 60% | - | - | - | n= 15 75% |
| Female | n= 3 9.37% | - | n=1 33.3% | n=2 66.66% | - | - | - | n= 2 66.66% | |
Table 2.
Demographic and clinical characteristics of data collected from patients with LRT pathological samples by age and sex
| Pathological samples | Comorbidities | number of patients with susceptible results to different antibiotic classes, other than beta-lactamins | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Age | Sex | 0 | 1 | ≥2 | AG | FQ | SXT | CT | Decesed | |
| <18 | Male | n= 1 3.33% | n=1 100% | - | - | - | - | - | - | |
| Female | n= 0 | - | - | - | - | - | - | - | - | |
| 19–60 | Male | n= 4 13.33% | - | n=4 100% | - | - | - | - | n=3 75% | n=3 75% |
| Female | n =0 | - | - | - | - | - | - | - | n=0 | |
| >61 | Male | n= 20 66.6% | n=2 10% | n=3 15% | n=15 75% | - | - | - | n=7 35% | n= 16 80% |
| Female | n= 5 16.66% | n=1 20% | n=1 20% | n=3 60% | - | - | - | n=4 75% | n= 3 60% | |
Fig. 3.
ERIC-PCR patterns of A. baumannii isolates
Fig. 4.
ERIC-PCR patterns of Klebsiella spp. isolates
Fig. 5.
ERIC-PCR patterns of P. aeruginosa isolates
Fig. 6.
ERIC-PCR patterns of S. maltophilia isolates